Search results
MDMA’s Future As A Treatment For PTSD Is In Question
Inverse· 3 hours agoWhile the FDA will still vote... and depression. Ahead of the vote, panelists described their concerns for the drug’s inability to undergo a double-blind study — the gold ...
Ecstasy’s Rebuff as PTSD Therapy Exposes Flawed Processes at FDA
Bloomberg· 6 days agoA federal panel’s near-unanimous opposition to an MDMA-based therapy for post-traumatic stress...
FDA objects to ecstasy for treating PTSD patients
The Washington Times· 6 days agoA nonbinding Food and Drug Administration panel rejected a proposal to use MDMA, or ecstasy, to treat post-traumatic stress disorder. Lykos Therapeutics...
FDA panel rejects ecstasy to treat PTSD
The Week via Yahoo News· 6 days agoLykos' two late-stage trials found vast improvements in a sizable majority of participants who got MDMA, but its data was "uncommonly messy," and the ...
F.D.A. Panel Rejects MDMA-Aided Therapy for PTSD
New York Times· 7 days agoBefore the vote, members of the panel raised concerns about the designs of the two studies submitted by the drug’s sponsor, Lykos Therapeutics. Many...
Psychedelic-medicine stocks drop after ecstasy’s rocky day at the FDA
Market Watch· 6 days agoPrivately held Lykos Therapeutics is seeking FDA approval for the treatment combining talk therapy...
What Is MDMA Therapy and What Are Its Risks?
New York Times· 7 days agoAn F.D.A. advisory panel dealt a setback to those seeking treatment for PTSD, citing health risks of the illegal drug and study flaws. The Food and Drug...
Ecstasy as a PTSD treatment gets thumbs down from FDA advisers
Market Watch· 7 days agoOne key issue: Due to the intense effects of MDMA, trial participants and researchers may have a...
FDA advisory panel votes against MDMA for treatment of PTSD
PhillyVoice.com· 6 days ago"Participants appear to experience rapid, clinically meaningful, durable...submitted by Lykos...
US health experts review MDMA as treatment for PTSD | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 7 days agoA panel of US health experts convened by the Food and Drug Administration (FDA) are meeting Tuesday...